SLC10A1 S267F variant influences susceptibility to HBV infection and reduces cholesterol level by impairing bile acid uptake

A functional polymorphism inlnc-LAMC2-1:1confers risk of colorectal cancer by affecting miRNA binding

(2016) Jing Gong et al.   CARCINOGENESIS

One small SNP for receptor virus entry, one giant leap for hepatitis B?

(2016) Neil Rajoriya et al.   GUT

The Hepatitis B Virus Receptor

(2015) Wenhui Li   Annual Review of Cell and Developmental Biology

The rs2296651 (S267F) variant on NTCP (SLC10A1) is inversely associated with chronic hepatitis B and progression to cirrhosis and hepatocellular carcinoma in patients with chronic hepatitis B

(2015) Hui-Han Hu et al.   GUT

The p.Ser267Phe variant inSLC10A1is associated with resistance to chronic hepatitis B

(2015) Liang Peng et al.   HEPATOLOGY

Metabolic effects of intestinal absorption and enterohepatic cycling of bile acids

(2015) Courtney B. Ferrebee et al.   Acta Pharmaceutica Sinica B

Association of Genetic Variation of Sodium Taurocholate Cotransporting Polypeptide with Chronic Hepatitis B Virus Infection

(2014) Na Li et al.   Genetic Testing and Molecular Biomarkers

Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism

(2014) Nicola Oehler et al.   HEPATOLOGY

Dysregulation of Retinoic Acid Receptor Diminishes Hepatocyte Permissiveness to Hepatitis B Virus Infection through Modulation of Sodium Taurocholate Cotransporting Polypeptide (NTCP) Expression

(2014) Senko Tsukuda et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Viral Entry of Hepatitis B and D Viruses and Bile Salts Transportation Share Common Molecular Determinants on Sodium Taurocholate Cotransporting Polypeptide

(2014) H. Yan et al.   JOURNAL OF VIROLOGY

Cyclosporin A and its analogs inhibit hepatitis B virus entry into cultured hepatocytes through targeting a membrane transporter, sodium taurocholate cotransporting polypeptide (NTCP)

(2013) Koichi Watashi et al.   HEPATOLOGY

HLA-DQpolymorphisms with HBV infection: different outcomes upon infection and prognosis to lamivudine therapy

(2013) X. Zhang et al.   JOURNAL OF VIRAL HEPATITIS

Molecular Determinants of Hepatitis B and D Virus Entry Restriction in Mouse Sodium Taurocholate Cotransporting Polypeptide

(2013) H. Yan et al.   JOURNAL OF VIROLOGY

The solute carrier family 10 (SLC10): Beyond bile acid transport

(2013) Tatiana Claro da Silva et al.   MOLECULAR ASPECTS OF MEDICINE

Structural basis of the alternating-access mechanism in a bile acid transporter

(2013) Xiaoming Zhou et al.   NATURE

Genetic variations in the TGF  signaling pathway, smoking and risk of colorectal cancer in a Chinese population

(2012) R. Zhong et al.   CARCINOGENESIS

Expression and Transport Function of Drug Uptake Transporters in Differentiated HepaRG Cells

(2012) Naoki Kotani et al.   MOLECULAR PHARMACEUTICS

Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus

(2012) Huan Yan et al.   eLife

Epidemiology of Hepatitis B and C Viruses: A Global Overview

(2010) Helen S. Te et al.   Clinics in Liver Disease

Hepatitis B: The virus and disease

(2010) T. Jake Liang   HEPATOLOGY

Bile acid transporters

(2009) Paul A. Dawson et al.   JOURNAL OF LIPID RESEARCH

Hepatitis B virus infection

(2009) Yun-Fan Liaw et al.   LANCET

Inhibition of intestinal absorption of cholesterol by ezetimibe or bile acids by SC-435 alters lipoprotein metabolism and extends the lifespan of SR-BI/apoE double knockout mice

(2007) Anne Braun et al.   ATHEROSCLEROSIS